Kumar Budur
Executive VP and Chief Medical & Scientific OfficerDr. Kumar Budur, MD, MS, serves as Executive Vice President and Chief Medical Officer at Harmony Biosciences, LLC since 2023. He is Chief Scientific Officer of Harmony Biosciences Holdings, Inc. from May 1, 2024. He is Executive VP & Chief Medical Officer of Harmony Biosciences Holdings, Inc. from May 2023. Dr. Budur served as Senior Vice President and Head of Clinical Development for Harmony. He is the senior Medical Director in Neuroscience Research and Drug Development at Takeda Pharmaceuticals. Dr. Budur is an Advisor at Equilateral Ventures. Prior to joining Takeda Pharmaceuticals, he was an Associate Professor of Medicine at Cleveland Clinic. Dr. Budur is double board certified in Psychiatry and in Sleep Medicine. He also has a Master’s Degree in Clinical Research from Case Western Reserve University, Cleveland, OH. Dr. Budur has been an angel investors in healthcare and bio-tech companies for over a decade.
Positions
- Company NameHarmony Biosciences Holdings, Inc.Stock CodeHRMYPositionExecutive VP and Chief Medical & Scientific OfficerColleagues
- JSJeffrey S. AroninFounder & Non-Executive Chairman
- JMJeffrey M. DaynoPresident, CEO & Director
- PAPeter AnastasiouSenior Executive VP & COO
- ASAndrew SerafinExecutive VP & Chief Strategy Officer
- AWAndreas WickiIndependent Director
- JAJuan Alfonso SabaterIndependent Director
- GLGary L. SenderIndependent Director
